Search Results - "Olagne, Jérome"
-
1
Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN
Published in Journal of the American Society of Nephrology (01-05-2017)“…In C3 glomerulopathy (C3G), the alternative pathway of complement is frequently overactivated by autoantibodies that stabilize the C3 convertase C3bBb…”
Get full text
Journal Article -
2
Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant Cohort
Published in Transplantation (01-10-2020)“…BACKGROUND.Donor-specific antibodies (DSA) play a major role in antibody-mediated rejection (AMR) and graft dysfunction. However, the clinical relevance of…”
Get full text
Journal Article -
3
Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis
Published in Kidney international reports (01-02-2022)Get full text
Journal Article -
4
New-onset systemic sclerosis and scleroderma renal crisis under docetaxel
Published in Journal of scleroderma and related disorders (01-10-2021)“…Systemic sclerosis is a rare systemic autoimmune disease characterized by microvascular impairment and fibrosis of the skin and other organs with poor…”
Get full text
Journal Article -
5
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
Published in JAMA : the journal of the American Medical Association (21-09-2021)“…All kidney transplant recipients followed up in the outpatient Kidney Transplantation Department of Strasbourg University Hospital between January 20, 2021,…”
Get full text
Journal Article -
6
Breakthrough COVID‐19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients
Published in American journal of transplantation (01-11-2022)“…The cilgavimab−tixagevimab combination retains a partial in vitro neutralizing activity against the current SARS‐CoV‐2 variants of concern (omicron BA.1,…”
Get full text
Journal Article -
7
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation
Published in American journal of transplantation (01-10-2023)“…Crescentic forms of immunoglobulin A nephropathy (IgAN) are rare but can be associated with rapid kidney failure and a high rate of end-stage renal disease…”
Get full text
Journal Article -
8
Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection
Published in American journal of transplantation (01-12-2020)“…The urinary chemokines CXCL9 and CXCL10 are promising noninvasive diagnostic markers of acute rejection (AR) in kidney recipients, but their levels might be…”
Get full text
Journal Article -
9
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients
Published in Transplantation (01-08-2023)Get full text
Journal Article -
10
-
11
-
12
Risk Factors for BK Virus Infection in the Era of Therapeutic Drug Monitoring
Published in Transplantation (27-06-2013)“…BACKGROUNDOverimmunosuppression is a widely recognized risk factor for BK virus (BKV) infection, particularly with the combination of tacrolimus, mycophenolate…”
Get full text
Journal Article -
13
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients
Published in Transplantation (01-01-2021)“…BACKGROUND:Data on COVID-19 in immunocompromised kidney transplant recipients (KTR) remain scanty. Although markers of inflammation, cardiac injury, and…”
Get full text
Journal Article -
14
B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS
Published in Journal of the American Society of Nephrology (01-08-2016)“…FSGS is a common glomerular disorder that has a high propensity for recurrence after kidney transplant. The pathophysiology of FSGS is unknown, but podocytes…”
Get full text
Journal Article -
15
C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features
Published in American journal of kidney diseases (01-09-2023)“…C3 glomerulopathy (C3GN) and atypical hemolytic uremic syndrome (aHUS) are 2 distinct rare kidney diseases caused by dysregulation of the alternative…”
Get full text
Journal Article -
16
Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group
Published in American journal of kidney diseases (01-06-2024)“…Atypical anti-glomerular basement membrane (GBM) nephritis is characterized by a bright linear immunoglobulin staining along the GBM by immunofluorescence…”
Get full text
Journal Article -
17
Loss of function of XBP1 splicing activity of IRE1α favors B cell tolerance breakdown
Published in Journal of autoimmunity (01-01-2024)“…Anti-nuclear antibodies are the hallmark of autoimmune diseases such as systemic lupus erythematosus (SLE) and scleroderma. However, the molecular mechanisms…”
Get full text
Journal Article -
18
Non-myeloma light chain cast nephropathy: a multicenter retrospective study on clinicopathological characteristics
Published in Haematologica (Roma) (01-08-2024)Get full text
Journal Article -
19
SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a “High-risk” Zone
Published in Transplantation (01-10-2021)“…Data on SARS-CoV-2 seroprevalence in kidney transplant recipients (KTR) remain rare. We sought to shed further light on this issue by conducting a…”
Get full text
Journal Article -
20
Glomerulonephritis with non-Randall-type, non-cryoglobulinaemic monoclonal immunoglobulin G deposits (PGNMID and ITG)
Published in Clinical kidney journal (01-09-2022)“…ABSTRACT Background Glomerulonephritis (GN) with non-Randall-type, non-cryoglobulinaemic monoclonal immunoglobulin G deposits encompasses rare diseases…”
Get full text
Journal Article